On the REPROCELL blog
Latest
Mapping the Competitive Landscape of Human Tissue-Based Drug Discovery
Explore how REPROCELL leads in human tissue-based drug discovery, addressing market gaps and offering innovative, disease-relevant solutions for better therapeutic outcomes.
02 April 2026
5 Hard Truths About Bringing Stem Cell Therapies to the Clinic
Discover the essential truths behind developing clinical-grade stem cell therapies and learn how to navigate the complexities of GMP manufacturing successfully.
30 March 2026
Donor Variability in Ex Vivo Human Tissue Studies: Challenge, Feature, or Translational Advantage
Explore how donor variability in ex vivo human tissue studies enhances translational research by providing insights into patient heterogeneity and improving drug discovery.
12 March 2026
REPROCELL Attends Japan-Maryland Night 2026
REPROCELL was honored to attend Japan-Maryland Night on Wednesday March 4th 2026 Maryland State, USA, hosted by the Embassy of Japan (in Washington DC).
06 March 2026